10-Q Filing

AVANOS MEDICAL, INC. CIK: 1606498 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001606498-17-000019`
Period End Date	20170331
Filing Date	20170502
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	hyh-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 28 Cash Flow Statement 42 Comprehensive Income 12

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$143.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$129.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$165.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$113.70M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, net of allowances	`AccountsReceivableNetCurrent`	$181.20M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, net of allowances	`AccountsReceivableNetCurrent`	$190.10M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Inventories	`InventoryNet`	$272.50M	USD	Point-in-time
Inventories	`InventoryNet`	$273.40M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$17.20M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	46.70M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$16.70M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	46.68M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$593.50M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$614.40M	USD	Point-in-time
Property, Plant and Equipment, net	`PropertyPlantAndEquipmentNet`	$260.80M	USD	Point-in-time
Property, Plant and Equipment, net	`PropertyPlantAndEquipmentNet`	$258.30M	USD	Point-in-time
Goodwill	`Goodwill`	$1.03B	USD	Point-in-time
Goodwill	`Goodwill`	$1.03B	USD	Point-in-time
Other Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$169.80M	USD	Point-in-time
Other Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$164.40M	USD	Point-in-time
Deferred Tax Assets	`DeferredIncomeTaxAssetsNet`	$15.80M	USD	Point-in-time
Deferred Tax Assets	`DeferredIncomeTaxAssetsNet`	$15.10M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$3.60M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$3.80M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.07B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.09B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$173.10M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$179.70M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$130.30M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$151.30M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$324.40M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$310.00M	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$579.40M	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$579.00M	USD	Point-in-time
Deferred Tax Liabilities	`DeferredIncomeTaxLiabilitiesNet`	$36.20M	USD	Point-in-time
Deferred Tax Liabilities	`DeferredIncomeTaxLiabilitiesNet`	$35.80M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$30.10M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$29.90M	USD	Point-in-time
Total Liabilities	`Liabilities`	$955.50M	USD	Point-in-time
Total Liabilities	`Liabilities`	$969.30M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value - authorized 20,000,000 shares, none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value - authorized 20,000,000 shares, none issued	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value - authorized 300,000,000 shares, 46,695,242 outstanding at March 31, 2017 and 46,681,798 outstanding at December 31, 2016	`CommonStockValue`	$500.00K	USD	Point-in-time
Common stock - $0.01 par value - authorized 300,000,000 shares, 46,695,242 outstanding at March 31, 2017 and 46,681,798 outstanding at December 31, 2016	`CommonStockValue`	$500.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.54B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.53B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-366.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-379.20M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$1.90M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$1.90M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-39.40M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-50.10M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$1.13B	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$1.10B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$2.07B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$2.09B	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
Net Sales	`SalesRevenueNet`	$395.60M	USD	1 Quarter
Net Sales	`SalesRevenueNet`	$384.80M	USD	1 Quarter
Cost of products sold	`CostOfGoodsSold`	$252.70M	USD	1 Quarter
Cost of products sold	`CostOfGoodsSold`	$248.30M	USD	1 Quarter
Gross Profit	`GrossProfit`	$142.90M	USD	1 Quarter
Gross Profit	`GrossProfit`	$136.50M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$8.00M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$8.70M	USD	1 Quarter
Selling and general expenses	`SellingGeneralAndAdministrativeExpense`	$92.80M	USD	1 Quarter
Selling and general expenses	`SellingGeneralAndAdministrativeExpense`	$101.20M	USD	1 Quarter
Other expense, net	`OtherOperatingIncomeExpenseNet`	$-7.40M	USD	1 Quarter
Other expense, net	`OtherOperatingIncomeExpenseNet`	$-1.90M	USD	1 Quarter
Operating (Loss) Profit	`OperatingIncomeLoss`	$33.10M	USD	1 Quarter
Operating (Loss) Profit	`OperatingIncomeLoss`	$26.30M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$400.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$200.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$7.60M	USD	1 Quarter
Interest expense	`InterestExpense`	$8.00M	USD	1 Quarter
(Loss) Income Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$19.10M	USD	1 Quarter
(Loss) Income Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$25.30M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$11.10M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$6.30M	USD	1 Quarter
Net Income	`NetIncomeLoss`	$12.80M	USD	1 Quarter
Net Income	`NetIncomeLoss`	$14.20M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.27	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.30	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.27	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.30	USD	1 Quarter

Cash Flow Statement 42 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$12.80M	USD	1 Quarter
Net income	`NetIncomeLoss`	$14.20M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$16.20M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.60M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$3.80M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$4.40M	USD	1 Quarter
Net loss on asset dispositions	`GainLossOnDispositionOfAssets1`	$-100.00K	USD	1 Quarter
Net loss on asset dispositions	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-8.10M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$16.60M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$900.00K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$5.20M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-3.10M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.30M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$11.20M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$19.40M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-19.60M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$2.60M	USD	1 Quarter
Other	`OtherOperatingActivitiesCashFlowStatement`	$3.50M	USD	1 Quarter
Other	`OtherOperatingActivitiesCashFlowStatement`	$5.50M	USD	1 Quarter
Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$42.50M	USD	1 Quarter
Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$37.00M	USD	1 Quarter
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$8.00M	USD	1 Quarter
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$10.20M	USD	1 Quarter
Cash Provided by (Used in) Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.00M	USD	1 Quarter
Cash Provided by (Used in) Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.20M	USD	1 Quarter
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	1 Quarter
Proceeds from the exercise of stock options	`ProceedsFromStockOptionsExercised`	$500.00K	USD	1 Quarter
Cash Provided by (Used in) Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Cash Provided by (Used in) Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$500.00K	USD	1 Quarter
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$2.10M	USD	1 Quarter
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$1.10M	USD	1 Quarter
Increase (Decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$29.40M	USD	1 Quarter
Increase (Decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$35.60M	USD	1 Quarter
Cash and Cash Equivalents - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$143.10M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$129.50M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$165.10M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$113.70M	USD	Point-in-time
Cash and Cash Equivalents - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$143.10M	USD	Point-in-time
Cash and Cash Equivalents - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$129.50M	USD	Point-in-time
Cash and Cash Equivalents - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$165.10M	USD	Point-in-time
Cash and Cash Equivalents - End of Period	`CashAndCashEquivalentsAtCarryingValue`	$113.70M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Income	`NetIncomeLoss`	$12.80M	USD	1 Quarter
Net Income	`NetIncomeLoss`	$14.20M	USD	1 Quarter
Unrealized currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$5.50M	USD	1 Quarter
Unrealized currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$9.80M	USD	1 Quarter
Defined benefit plans	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-200.00K	USD	1 Quarter
Defined benefit plans	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Cash flow hedges	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	$1.10M	USD	1 Quarter
Cash flow hedges	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	$700.00K	USD	1 Quarter
Total Other Comprehensive Income, Net of Tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$6.60M	USD	1 Quarter
Total Other Comprehensive Income, Net of Tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$10.70M	USD	1 Quarter
Comprehensive Income	`ComprehensiveIncomeNetOfTax`	$23.50M	USD	1 Quarter
Comprehensive Income	`ComprehensiveIncomeNetOfTax`	$20.80M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.